Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kakolyris

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|September 15, 2001
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanesK Kalbakis, C Kouroussis, S Kakolyris, et al.
American Journal of Clinical Oncology|June 11, 1999
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancerS Kakolyris, G Samonis, M Koukourakis, et al.
Chemotherapy|October 8, 2010
Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancerL Chelis, N Xenidis, K Amarantidis, et al.
Seminars in Oncology|March 4, 2000
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary reportD Mavroudis, C Kourousis, S Kakolyris, et al.
Cancer|November 25, 1998
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbineC Kourousis, N Androulakis, S Kakolyris, et al.
British Journal of Cancer|July 4, 1998
Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survivalM I Koukourakis, A Giatromanolaki, S Kakolyris, et al.
Cancer Research|December 20, 1999
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expressionS Kakolyris, A Giatromanolaki, M Koukourakis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trialM I Koukourakis, C Kourousis, M Kamilaki, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancerK Tryfonidis, I Boukovinas, N Xenidis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumoursN Androulakis, C Kouroussis, D Mavroudis, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|September 15, 2001
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanesK Kalbakis, C Kouroussis, S Kakolyris, et al.
American Journal of Clinical Oncology|June 11, 1999
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancerS Kakolyris, G Samonis, M Koukourakis, et al.
Chemotherapy|October 8, 2010
Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancerL Chelis, N Xenidis, K Amarantidis, et al.
Seminars in Oncology|March 4, 2000
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary reportD Mavroudis, C Kourousis, S Kakolyris, et al.
Cancer|November 25, 1998
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbineC Kourousis, N Androulakis, S Kakolyris, et al.
British Journal of Cancer|July 4, 1998
Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survivalM I Koukourakis, A Giatromanolaki, S Kakolyris, et al.
Cancer Research|December 20, 1999
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expressionS Kakolyris, A Giatromanolaki, M Koukourakis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trialM I Koukourakis, C Kourousis, M Kamilaki, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancerK Tryfonidis, I Boukovinas, N Xenidis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumoursN Androulakis, C Kouroussis, D Mavroudis, et al.
Pageof 13